Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical ropivacaine after mandibular orthognathic surgery
IRCT20181023041425N2Phase 3Completed
- Sponsor
- Ghaem Hospital
- Start
- Apr 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ropivacaine in mandibular defect (2 arms), sponsored by Ghaem Hospital. Primary endpoints: Postoperative pain reduction, Postoperative nausea reduction and 1 more. Started Apr 2020; status: completed.
02
Drugs
ropivacaine
03
Conditions
mandibular defect
Beyond the preview
Go deeper on IRCT20181023041425N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181023041425N2.